Philips introduces non-invasive foetal monitor for
27 October 2006
Andover, Mass. USA. The increasing number of high-risk
pregnancies with multiple foetuses has led Royal Philips
(NYSE: PHG, AEX: PHI) to develop the triplet-monitoring
functionality for its industry-leading line of obstetrical
care foetal and maternal monitors. Philips says that the
Avalon FM20 antepartum and Avalon FM30 intrapartum monitors
that it has introduced to market are the first devices to
enable non-invasive triplet monitoring with a single device.
“With the worldwide increase in the birth rate for triplets, we’re
pleased to pioneer non-invasive triplets monitoring in a single
monitor,” said David Russell, vice president of global marketing,
patient monitoring, for Philips Medical Systems.
High-risk pregnancies with multiples require vigilant obstetrical care.
Their incidence is rising due to older mothers and the use of fertility
therapies. In the last two decades the number of higher order multiples
births (triplets or more) in the U.S. has increased substantially, according
to the National Center for Health Statistics.
Built on Philips industry-leading IntelliVue patient monitoring
platform, Avalon FM20 antepartum monitors and Avalon FM30 intrapartum
monitors use three channels of high-quality ultrasound tracing and check
coincidence between the heart rates of the mother and all foetuses to
help ensure each foetus is being monitored. The monitor displays the
three foetal heart rates, along with the mother’s heart rate, on a
Two features help clinicians sort out multiple foetal heart traces.
Trace Separation allows users to stack multiple traces along the
vertical scale, which adjusts to ensure the traces can be read clearly.
Users can also assign a different line thickness to each foetal heart
The Transducer Finder feature identifies which transducer is
monitoring each heart rate. When a user selects any foetal heart rate on
the monitor display, the corresponding transducer lights up.
Both Avalon FM20 and FM30 track maternal blood pressure, pulse and
uterine activity. The Avalon FM30 also monitors maternal SpO2
and ECG. It covers patients from the onset of contractions through the
final stages of delivery with its full set of external and internal
fetal parameters, such as ultrasound and direct foetal heart rate, toco
and intrauterine pressure.
Data from the monitors can be automatically transmitted to the
Philips OB TraceVue obstetrical information system for comprehensive
information management across the obstetrical care continuum, from the
beginning of pregnancy through postpartum visits, as well as across